Diphenyl Pyraline

Diphenyl Pyraline (HCl) is a H1 receptor antagonist with anticholinergic and seddative effects. Diphenyl Pyraline (HCl) is used as antihistaminic agent in the treatment of allergic symptoms. Diphenyl Pyraline (HCl) is administered orally.

Brands
CONTAC-650 SPANSULA
Adult Dose
Neonatal
Paedriatic
Characteristics
Diphenyl Pyraline (HCl) is the derivative of Diphenyl Pyraline. It is of Synthetic origin and belongs to Aminio alkyle ether. . The Molecular Weight of Diphenyl Pyraline is 317.90.
Contraindications
Diphenyl Pyraline is contraindicated in conditions like Heart disease,Jaundice,Urinary tract infection,Glaucoma.
Effects
The severe or irreversible adverse effects of Diphenyl Pyraline, which give rise to further complications include Anemia, Anemia, Hypotension, Hypotension, Paresthesia, Anemia, Anemia.Diphenyl Pyraline produces potentially life-threatening effects which include Convulsions. which are responsible for the discontinuation of Diphenyl Pyraline therapy.The signs and symptoms that are produced after the acute overdosage of Diphenyl Pyraline include Extrapyramidal effects, CNS effects.The symptomatic adverse reactions produced by Diphenyl Pyraline are more or less tolerable and if they become severe, they can be treated symptomatically, these include Drowsiness, Myalgia, Insomnia, Rashes, Confusion, Sedation, SweatingX, Diplopia, Sensitivity, Confusion.
Indications
Diphenyl Pyraline is primarily indicated in conditions like Cold, Cough, Pruritus, Rhinitis, Skin diseases, and can also be given in adjunctive therapy as an alternative drug of choice in Parkinsonism.
Interactions
No data regarding the interactions of Diphenyl Pyraline was found.
Interfrence
Risks
Drug should not be given to Paediatrics, and Neonates.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Storage
Warnings
Diphenyl pyraline should be used with caution in bone marrow depression. Patients should observe caution while driving or performing other task requiring alertness because it may cause drowsiness. It should be used with caution in patients with urinary retention, history of bronchial asthma, hyperthyroidism, cardiovascular or liver disease. It should be used with caution in person with acute or chronic respiratory impairment, especially in children. Do not administer S/C because irritation or lesion may occur.
Back to List

Any information that appears on this website page is provided for the purpose of general information. This website has been compiled in good faith by HMIS.Online. However, no guarantee is made as to the completeness, validity or accuracy of the information it contains.